iKang Healthcare Group, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Mar 31, 2014
ASSETS
Current assets
Cash and cash equivalents
Restricted cash
Term deposits
Accounts receivable, net of allowance for doubtful accounts of $14,261 and $23,142 as of March 31, 2017 and 2018, respectively
Inventories
Deferred tax assets-current
Amount due from related parties
Prepaid expenses and other current assets
Total current assets
Restricted cash-non-current
Property and equipment, net
Acquired intangible assets, net
Goodwill
Cost method investment
Equity method investment
Long-term investments
Deferred tax assets-non-current
Rental deposit and other non-current assets
TOTAL ASSETS

LIABILITIES AND EQUITY
Current liabilities
Accounts payable (including accounts payable of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $34,637 and $43,840 as of March 31, 2017 and 2018, respectively)
Accrued expenses and other current liabilities (including accrued expenses and other current liabilities of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $48,910 and $60,281 as of March 31, 2017 and 2018, respectively)
Income tax payable (including income tax payable of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $6,414 and $13,523 as of March 31, 2017 and 2018, respectively)
Deferred revenues (including deferred revenues of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $57,361 and $87,388 as of March 31, 2017 and 2018, respectively)
Deferred government subsidy-current (including deferred government subsidy - current of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $63 and nil of March 31, 2015 and 2016, respectively)
Short-term borrowings (including short-term borrowings of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $56,772 and $53,364 of March 31, 2015 and 2016, respectively)
Convertible loan (including convertible loan of the consolidated VIE entities without recourse to iKang Healthcare Group, Inc. of nil and nil of March 31, 2013 and 2014, respectively)
Amounts due to related parties (including amounts due to related parties of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of nil and $3,480 as of March 31, 2017 and 2018, respectively)
Short term borrowings (including short term borrowings of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $111,299 and $196,450 as of March 31, 2017 and 2018, respectively)
Total current liabilities

Deferred government subsidy - non-current (including deferred government subsidy-non-current of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc of $63 and nil of March 31, 2014 and 2015, respectively)
Long term borrowings (including long term borrowings consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $1,865 and nil of March 31, 2014 and 2015, respectively)
Long-term borrowings (including long term borrowings of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of 101,697 and $38,884 as of March 31, 2017 and 2018, respectively)
Deferred tax liabilities-non-current (including deferred tax liabilities-non-current of the consolidated VIEs and VIEs' subsidiaries without recourse to iKang Healthcare Group, Inc. of $7,009 and $4,944 as of March 31, 2017 and 2018, respectively)
TOTAL LIABILITIES
Convertible redeemable participating preferred shares
Series A convertible redeemable participating preferred shares
Series B convertible redeemable participating preferred shares
Series C1 convertible redeemable participating preferred shares
Series C2 convertible redeemable participating preferred shares
Series C3 convertible redeemable participating preferred shares
Series D1 convertible redeemable participating preferred shares
Series D2 convertible redeemable participating preferred shares
Series E convertible redeemable participating preferred shares
Series F convertible redeemable participating preferred shares
Equity
iKang Healthcare Group, Inc. shareholders' equity
Common shares
Class A common shares
Class B common shares
Class C common shares

Additional paid-in capital
Statutory reserve
Accumulated deficit
Accumulated other comprehensive loss
Total iKang Healthcare Group, Inc. shareholders' equity
Non-controlling interests
TOTAL EQUITY
TOTAL LIABILITIES AND EQUITY

Comments